PharmTech Drug Digest 11.20
News|Articles|August 5, 2011

Rapid identification of Genotoxic Impurities in Tablets with Xevo TQD

Xevo TQD provides ultimate consistency between analyses; instrument to instrument, lab to lab; both the advanced technology of the ACQUITY UPLC System and the robust universal ion source architecture on the Xevo TQD guarantee flexibility and dependability.

Xevo TQD provides ultimate consistency between analyses; instrument to instrument, lab to lab; both the advanced technology of the ACQUITY UPLC System and the robust universal ion source architecture on the Xevo TQD guarantee flexibility and dependability.

Genotoxic impurities at the Threshold of Toxicological Concern (TTC) can easily be identified with the Xevo TQD. A rapid, simple and powerful approach that brings productivity gains to a routine laboratory setting that has not been possible before.

Learn more


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.